Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
| Catalog No. | Product Name | Size | List Price (US$) | Quantity |
|---|
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Background Information:
Varespladib Sodium is a secretory phospholipase A2 (sPLA2) inhibitor, a water-soluble Intravenous version of the molecule Varespladib, currently being evaluated as an anti-inflammatory sPLA2 inhibitor for the prevention of acute chest syndrome (ACS), the leading cause of death for patients with sickle-cell disease.
APIM050365: VARESPLADIB SODIUM (LY315920 SODIUM SALT)
CAS No.: 172733-42-5.
Molecular Formula: C21H19N2O5Na.
Molecular Weight: 402.4.
Purity: 99.9% by HPLC at 214and 254 nm.
QC: HPLC, 1H-NMR, and quantitative elemental analysis report.
Solubility: Soluble in water (20.1mg/ml, >50 mM).
Storage: Refer to certificate of analysis.
Copyright © 2009-2022 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.